» Articles » PMID: 36571080

Hydrogel Derived from Glucomannan-Chitosan to Improve the Survival of FNCC 0051 in Simulated Gastrointestinal Fluid

Overview
Publisher Wiley
Specialty Biology
Date 2022 Dec 26
PMID 36571080
Authors
Affiliations
Soon will be listed here.
Abstract

The probiotic encapsulating hydrogel derived from porang () glucomannan and chitosan was investigated with regard to its encapsulation efficiency, physical properties, prebiotic activity, and survival under simulated gastrointestinal conditions. The hydrogel's encapsulation efficiency was improved by varying the number of the FNCC 0051, which also served to increase the diameter (2-3 mm), polydispersity index (1.23-1.65), positive zeta potential, whiteness, and brightness of the hydrogel. Moreover, the hydrogel's prebiotic activity score was higher than that of inulin after 24 h of incubation, reflecting its role as a cell encapsulant, particularly when it comes to maintaining cells during exposure to simulated gastrointestinal fluid. The cell viability increased from 86% to 100% when immersed in intestinal juice, which is comparable to the increase achieved using alginate and konjac glucomannan hydrogels. Future animal studies are required to determine the cell viability in actual gastrointestinal conditions and assess the health effects of the hydrogel.

References
1.
Zeashan M, Afzaal M, Saeed F, Ahmed A, Tufail T, Ahmed A . Survival and behavior of free and encapsulated probiotic bacteria under simulated human gastrointestinal and technological conditions. Food Sci Nutr. 2020; 8(5):2419-2426. PMC: 7215207. DOI: 10.1002/fsn3.1531. View

2.
Stasiak-Rozanska L, Berthold-Pluta A, Pluta A, Dasiewicz K, Garbowska M . Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations. Int J Environ Res Public Health. 2021; 18(3). PMC: 7908519. DOI: 10.3390/ijerph18031108. View

3.
Collnot E, Ali H, Lehr C . Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release. 2012; 161(2):235-46. DOI: 10.1016/j.jconrel.2012.01.028. View

4.
Korkiatithaweechai S, Umsarika P, Praphairaksit N, Muangsin N . Controlled release of diclofenac from matrix polymer of chitosan and oxidized konjac glucomannan. Mar Drugs. 2011; 9(9):1649-1663. PMC: 3225940. DOI: 10.3390/md9091649. View

5.
Ding X, Xu Y, Wang Y, Xie L, Liang S, Li D . Carboxymethyl konjac glucomannan-chitosan complex nanogels stabilized double emulsions incorporated into alginate hydrogel beads for the encapsulation, protection and delivery of probiotics. Carbohydr Polym. 2022; 289:119438. DOI: 10.1016/j.carbpol.2022.119438. View